We are live on ! Find out more
AHPI

Allied Healthcare Products

Delisted

AHPI was delisted on the 2nd of February, 2023.

12 hedge funds and large institutions have $1.04M invested in Allied Healthcare Products in 2018 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1212 (0)

14% less capital invested

Capital invested by funds: $1.21M → $1.04M (-$168K)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

Holders
12
Holders Change
Holders Change %
0%
% of All Funds
0.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
3
Reduced
4
Closed
Calls
Puts
Net Calls
Net Calls Change

AHPI Hedge Fund Activity: Q3 2018 in Review

12 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Allied Healthcare Products (AHPI) for Q3 2018, worth a combined $1.04M — down 14% from $1.21M a quarter earlier.

Fund positioning in AHPI was balanced in Q3 2018: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 4 trimmed.

The largest buyer was UBS Group, adding an estimated $5.21K. The largest seller was Dimensional Fund Advisors, cutting an estimated $30.7K.

  • 12 institutional investors held Allied Healthcare Products (AHPI) as of Q3 2018, unchanged from Q2 2018.
  • Funds reported $1.04M of Allied Healthcare Products stock for Q3 2018, down 14% quarter-over-quarter.
  • 0 funds opened new Allied Healthcare Products positions in Q3 2018 and 0 closed out.
  • The largest Allied Healthcare Products buyer in Q3 2018 was UBS Group, an estimated $5.21K added.
  • The largest Allied Healthcare Products seller in Q3 2018 was Dimensional Fund Advisors, an estimated $30.7K sold.

Based on aggregated 13F filings for Q3 2018.